CD133 expression may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer stem cell hypothesis: a meta-analysis

We performed a meta-analysis of CD133-related clinical data to investigate the role of cancer stem cells (CSCs) in the clinical outcomes of colorectal cancer (CRC) patients, analyzing the effectiveness of various therapeutic strategies and examining the validity of the CSC hypothesis. For 28 studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yang, Peng, Jing, Zhang, Enlong, Jiang, Ning, Li, Jiang, Zhang, Qi, Zhang, Xuening, Niu, Yuanjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891101/
https://www.ncbi.nlm.nih.gov/pubmed/26840260
http://dx.doi.org/10.18632/oncotarget.7054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891101/
https://www.ncbi.nlm.nih.gov/pubmed/26840260
http://dx.doi.org/10.18632/oncotarget.7054

Ejemplares similares